In particular, thyroid nodules with IR US and AUS/FLUS FNAB exhibited a significantly different probability of PTC according to BRAF mutation status (negative, 29.2% vs positive, 87.5%; P < 0.001). This evidence concerns the gene BRAF and thyroid nodule.